Pharmaron is a leading global pharmaceutical R&D service provider that supports drug discovery, development, and commercialization [9]. The organization maintains a comprehensive network of internationally accredited facilities, demonstrating consistent regulatory compliance through multiple agency certifications and inspections.
- Continuous AAALAC accreditation since 2007 with regular renewals
- Successful FDA inspections (2009-2019)
- NMPA/CFDA GLP, UK-MHRA GLP, and OECD GLP certifications [5]
- 215,000 ft² Beijing TSP facility [5]
- 2.6 million ft² Ningbo campus [8]
- 473,000 ft² Hoddesdon integrated discovery center [6]
- Specialized facilities in Germantown, Boston, and Rushden [3]
- Drug Discovery Services:
- Manufacturing Operations:
- 38 patent applications and publications with MSD Research Laboratories
- 41 patent applications and publications with Genentech
- Long-term partnership with Lycera supporting clinical advancement [4]
- Regular scientific presentations at major industry conferences
- Comprehensive webinar series covering DMPK and drug discovery
- Academic partnerships with leading institutions [3]
- Continuous learning initiatives
- Future scientific leadership development
- Innovation advancement [7]
The company's commitment to excellence is further demonstrated through successful regulatory compliance and quality management systems that enable worldwide IND and NDA filings [9]. This comprehensive approach to pharmaceutical research and development positions Pharmaron as a trusted partner in advancing therapeutic innovations across the global pharmaceutical industry.